DGAP-News

Vita 34 AG Publishes Financial Figures for the First Half-Year 2014 - Seite 3

achieve its targets for the full year 2014.

The complete six-month report 2014 is available for download as of today on
the website at www.vita34group.de in the "Investor Relations" section.

Company Profile

Vita 34 was founded in 1997 as the first private umbilical cord blood bank
in Europe and, as a complete provider, offers collection logistics,
preparation and storage of umbilical cord blood and tissue. The basis for
its successful work is an outstanding position in the technological segment
of cryo-preservation. Here, cells and tissues are preserved alive at
temperatures around minus 190 degrees Celsius, and can be used if needed in
the context of medical treatment. Parents of nearly 106,000 children are
already taking advantage of this offering and have provided for their
children with a stem cell deposit at Vita 34. To date, 26 therapeutic
applications have been performed with stem cell preparations stored at Vita
34.



End of Corporate News

---------------------------------------------------------------------

24.07.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language: English
Company: Vita 34 AG
Deutscher Platz 5a
04103 Leipzig
Germany
Phone: [phone]
Fax: [phone]
E-mail: [e-mail]
Internet: www.vita34.de
ISIN: DE000A0BL849
WKN: A0BL84
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart


End of News DGAP News-Service
---------------------------------------------------------------------
279106 24.07.2014